Table 5.
Vehicle |
Cisplatin |
|||||
---|---|---|---|---|---|---|
Male | Female | P-value | Male | Female | P-value | |
Animal number | 5 | 5 | 4 | 5 | ||
BUN (mg/dl) | 22.3 ± 1.2 | 20.9 ± 1.1 | >0.05 | 31.2 ± 2.2 | 22.9 ± 1.5 | <0.01 |
Cr (mg/dl) | 0.14 ± 0.03 | 0.11 ± 0.02 | >0.05 | 0.27 ± 0.03 | 0.21 ± 0.01 | <0.01 |
CrCl (ml/min/100g BW) | 1.01 ± 0.06 | 0.94 ± 0.05 | 0.08 | 0.75 ± 0.03 | 0.85 ± 0.04 | <0.05 |
Plasma Pi (mg/dl) | 6.92 ± 0.48 | 6.67 ± 0.31 | >0.05 | 7.41 ± 0.27 | 6.38 ± 0.21 | <0.01 |
Plasma Ca (mg/dl) | 9.31 ± 0.45 | 9.23 ± 0.32 | >0.05 | 9.12 ± 0.45 | 9.19 ± 0.32 | >0.05 |
Plasma PTH (pg/ml) | 165 ± 16 | 147 ± 10 | >0.05 | 303 ± 36 | 290 ± 19 | >0.05 |
Plasma 1,25-(OH)2D3 (pg/ml) | 78.2 ± 6.4 | 89.8 ± 11.7 | 0.087 | 27.1 ± 2.7 | 34.6 ± 3.6 | <0.05 |
Plasma FGF23 (pg/ml) | 155 ± 78 | 140 ± 45 | >0.05 | 1308 ± 219 | 883 ± 102 | <0.01 |
Heart weight/body weight (mg/g) | 5.13 ± 0.29 | 4.89 ± 0.14 | >0.05 | 5.23 ± 0.39 | 5.11 ± 0.21 | >0.05 |
Data were presented as means ± SD at 20 weeks. The statistical significance was analyzed by unpaired Student t-test